NL-OMON30316尚未招募不适用
Biomarker detection for benign breast diseases and primary breast cancer by serum and tissue protein profiling. - Breast Cancer Proteomics study (BCP study)
Slotervaartziekenhuis0 个研究点目标入组 380 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 380
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Female patients diagnosed with benign breast disease or primary breast cancer (that will be treated surgically) by breast biopsy at the Department of Surgery of the Slotervaart Hospital in Amsterdam.
- •2. Female patients diagnosed with benign breast disease and treated surgically the Department of Surgery of the Slotervaart Hospital in Amsterdam.
- •3. Female patients undergoing breast reduction surgery at the Department of Plastic Surgery of the Slotervaart Hospital in Amsterdam.
- •4. Age > 18yrs.
- •5. Able and willing to undergo blood and tissue sampling for protein analysis.
排除标准
- •1. Known history of (treated) malignancies.
- •2. Incapacity of participant to give written informed consent.
- •3. Patients not able to undergo blood and tissue sampling for protein analysis.
- •4. Any psychological, familial, sociological or geographical condition that may potentially interfere with compliance to the study protocol.
研究者
相似试验
已完成
2 期
Detection of early premalignant breast lesions by autofluorescence ductoscopybreast cancerNL-OMON40131niversitair Medisch Centrum Utrecht30
已完成
不适用
Improved diagnosis of clinically occult breast lesionsbreast neoplasms10006291breast cancerNL-OMON38092niversitair Medisch Centrum Utrecht128
进行中（未招募）
1 期
Multihance versus Dotarem at 3 Teslathe aim of this study is to intraindividually compare the use of equivalent doses of gadobenate dimeglumine (MultiHance, Bracco Imaging, Milan, Italy) and gadoterate meglumine (DOTAREM, Guerbet, France) for breast MR imaging by using a prospective study design, evaluated independently by blinded readers.EUCTR2011-005498-21-ATMed. Univ. Wien, Univ. Klinik für Radiodiagnostik130
已完成
不适用
Detectability of breast lesions of dense breast using low-dose computed tomographyBreast lesionsJPRN-UMIN000029145Hokkaido University80
进行中（未招募）
不适用
Breast cancer biomarkers and treatment targetsMalignant neoplasm of breastBreast cancerCancerISRCTN40576403niversity Hospital Southampton (UK)500